G. Montalto et al., INFLUENCE OF HEMODIALYSIS ON LIPASE ACTIVITY, European journal of clinical chemistry and clinical biochemistry, 35(3), 1997, pp. 237-238
Our aim was to determine whether the increase in serum pancreatic lipa
se values, reported in patients with chronic renal failure maintained
on haemodialysis, is the result of haemoconcentration by fluid removal
during dialysis, or whether it is due to lipase stimulation by endoth
elial lipoprotein lipase, induced by the heparin used as an anticoagul
ant. We therefore compared the increases in serum lipase, when heparin
was used, with those observed when this was replaced by the antithrom
botic agent, defibrotide, which has no effect on lipoprotein lipase. I
n addition, in order to determine the effects of haemoconcentration, v
ariations in total protein concentration and haematocrit values were d
etermined on the same samples, both before and after dialysis. The res
ults showed a statistically significant post-dialysis increase in lipa
se only when heparin was used (p <0.03). There was also a mean percent
age post-dialysis increase of 16.2% in total protein (p <0.0001) and 1
5.5% in haematocrit (p <0.0001), due to fluid removal. No significant
correlation in percentage increases was found between lipase vs total
protein or haematocrit values. These findings suggest that heparin-ind
uced lipoprotein lipase stimulation is the principal cause of the post
-dialysis increase in pancreatic lipase, and that fluid removal during
dialysis makes only a minor contribution to this increase.